CLINICAL_TRIALS
trial_result
· 2021-01-15
Clinical Trial Update: Safety and Efficacy Study of NBI-98854 in Children and Adolescents With Tourette Syndrome [Phase 2]
Summary
Phase 2 trial of NBI-98854 in children and adolescents with Tourette syndrome completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Neurocrine Biosciences | Conditions: Tourette Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2021-01-15